drugset / Trial / NCT02465008

Analgesic Effect of Levobupivacaine in Breast Augmentation

NCT02465008

Phase 4 Suspended 66 enrolled General University Hospital of Valencia
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether levobupivacaine is effective in the acute postoperative pain treatment in periprosthetic breast augmentation

Timeline

Start
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Levobupivacaine Other / unclassified 150 mg Other

Indications

No indication recorded.